Miroculus

Fay
Christodoulou

Year of Selection

2020

field

Healthtech, Diagnostics

employees

45

website

https://miroculus.com/
To advance science and improve lives faster, together.

COMPANY DESCRIPTION

Miroculus is building a new operating system for life sciences. It is a toolbox that includes an instrument, a plastic consumable and a software that will allow thousands of scientists, engineers, hospitals and lab operators all over the world to create, share, download and run the most complex protocols and tests in a fully automated fashion at no additional cost. Miroculus has developed a proprietary technology — Miro technology — based on digital microfluidics to automate and miniaturize genomic protocols such as Next Generation Sequencing library preparation, synthetic biology, cell editing, and combinatorial chemistry, in a compact, user-friendly system. Miroculus IP extends to over 25 patent applications within 13 different patent families. The Miro technology utilizes electromechanical forces to actuate droplets on the surfaces of insulated electrodes, without requiring immersion in oil or direct contact with system electronics.

BIO

Fay’s work has been published in Nature, Cell and Science. In 2012 she was awarded an EU postdoctoral fellowship to investigate the role of microRNAs in thyroid carcinogenesis in the Biomedical Research Foundation of the Academy of Athens, Greece. Following that, she was awarded the 1st prize of the Hellenic Association of Pharmaceutical Companies Innovation Project for her scientific contribution. Fay completed her PhD at the European Molecular Biology Laboratory in Heidelberg, Germany.

Copy link
Powered by Social Snap